EVA Live, Inc. announced the launch of NeuroServe, a next‑generation AI‑driven advertising platform, on February 3 2026. The platform is designed to automatically adjust delivery and targeting in real time, replacing manual optimization with instant decision‑making and aiming to improve campaign performance while reducing human error.
NeuroServe was built over a two‑year development cycle that included beta testing with online advertisers and lead‑generation partners in 2025. Stress‑testing conducted by select agencies and partners validated the platform’s performance, stability, and scalability under real‑world traffic conditions, confirming its readiness for enterprise‑scale deployment.
The launch follows EVA Live’s transformation from a gaming shell to a high‑margin AI ad‑arbitrage business. NeuroServe is positioned as the company’s core revenue‑generating product, with management projecting it will capture a growing share of the $500 billion global online advertising market and become the leading product by sales by the end of 2026. The platform expands EVA Live’s product portfolio beyond its existing Eva and Eva XML offerings and is intended to broaden the company’s addressable market in the competitive programmatic space.
EVA Live’s Q2 2025 results showed a turnaround to profitability and strong revenue growth, setting the stage for the NeuroServe launch. The company’s recent uplisting to Nasdaq on January 29 2026 has drawn attention from investors and analysts, underscoring the significance of the new platform as a catalyst for future growth.
EVA Live’s leadership emphasized the platform’s potential to transform campaign management and deliver higher returns on marketing budgets for advertisers, reinforcing the company’s strategic focus on AI‑driven advertising technology.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.